Clinical Trial Update: Examination of Plasma Concentrations and Safety in Chronic Kidney Disease Patients Undergoing Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating pharmacokinetics and safety of ASP7991 in chronic kidney disease patients on hemodialysis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• ASP7991

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Patients on Stable Chronic Maintenance Dialysis Who Are Receiving Hemodialysis Therapy, Pharmacodynamics of ASP7991 | Phase 1 | Status: COMPLETED